insights_auto
Why is PLUR up 4.01%?
Dive Deeperchevron_right
PLUR:NASDAQ
Pluri Inc
$1.01
arrow_upward
+4.01%(+0.039) 1D
$0.96
arrow_downward
-4.86% (-0.049)bedtimeAfter hours
Closed: Sep 29, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLUR...
Open
$0.97
High
$1.04
Low
$0.97
Mkt. cap
12.46M
Avg. vol.
26.04K
Volume
14.58K
52-wk high
$4.86
52-wk low
$0.90
EPS
-$2.44
Beta
0.68
Shares outstanding
12.34M
No. of employees
92
Open
$0.97
High
$1.04
Low
$0.97
Mkt. cap
12.46M
Avg. vol.
26.04K
Volume
14.58K
52-wk high
$4.86
52-wk low
$0.90
EPS
-$2.44
Beta
0.68
Shares outstanding
12.34M
No. of employees
92
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 months ago
PLUR Q2 2026 Earnings: Wider-than-Expected Loss as Revenue Remains Absent - Earnings Weakness Phase
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees92
FoundedMay 11, 2001
HeadquartersHaifa, Haifa District, Israel
SectorBiotechnology
Websitepluri-biotech.com